Previously, the protein truncating variations in WT1 have been shown to attenuate the TP53-induced DNA damage response in T-cell acute lymphoblastic leukemia (Bordin et al., 2018). This evidence concerns the gene TP53 and T-cell acute lymphoblastic leukemia.